
Mark L. Berch
Examiner (ID: 99)
| Most Active Art Unit | 1202 |
| Art Unit(s) | 1202, 1624, 1622, 1802, 2899, 1614, 1611 |
| Total Applications | 3573 |
| Issued Applications | 2301 |
| Pending Applications | 170 |
| Abandoned Applications | 1103 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7338228
[patent_doc_number] => 20040132996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-08
[patent_title] => 'Method for preparation of ceftiofur and salts thereof'
[patent_app_type] => new
[patent_app_number] => 10/694619
[patent_app_country] => US
[patent_app_date] => 2003-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7518
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20040132996.pdf
[firstpage_image] =>[orig_patent_app_number] => 10694619
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/694619 | Method for preparation of ceftiofur and salts thereof | Oct 26, 2003 | Issued |
Array
(
[id] => 7207357
[patent_doc_number] => 20040087587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions'
[patent_app_type] => new
[patent_app_number] => 10/693069
[patent_app_country] => US
[patent_app_date] => 2003-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54829
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20040087587.pdf
[firstpage_image] =>[orig_patent_app_number] => 10693069
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/693069 | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions | Oct 23, 2003 | Abandoned |
Array
(
[id] => 7336980
[patent_doc_number] => 20040132708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-08
[patent_title] => 'Process for preparing 6-alkylidene penem derivatives'
[patent_app_type] => new
[patent_app_number] => 10/693315
[patent_app_country] => US
[patent_app_date] => 2003-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88695
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20040132708.pdf
[firstpage_image] =>[orig_patent_app_number] => 10693315
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/693315 | Process for preparing 6-alkylidene penem derivatives | Oct 23, 2003 | Abandoned |
Array
(
[id] => 509919
[patent_doc_number] => 07199127
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-03
[patent_title] => 'Purine nucleosides'
[patent_app_type] => utility
[patent_app_number] => 10/530552
[patent_app_country] => US
[patent_app_date] => 2003-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 25098
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/199/07199127.pdf
[firstpage_image] =>[orig_patent_app_number] => 10530552
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/530552 | Purine nucleosides | Oct 23, 2003 | Issued |
Array
(
[id] => 7367891
[patent_doc_number] => 20040092520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Purine compounds and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/689381
[patent_app_country] => US
[patent_app_date] => 2003-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43745
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20040092520.pdf
[firstpage_image] =>[orig_patent_app_number] => 10689381
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/689381 | Purine compounds and uses thereof | Oct 19, 2003 | Issued |
Array
(
[id] => 7208809
[patent_doc_number] => 20050043531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Process for preparing cefepime'
[patent_app_type] => utility
[patent_app_number] => 10/688606
[patent_app_country] => US
[patent_app_date] => 2003-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2246
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20050043531.pdf
[firstpage_image] =>[orig_patent_app_number] => 10688606
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/688606 | Process for preparing cefepime | Oct 16, 2003 | Abandoned |
Array
(
[id] => 7161526
[patent_doc_number] => 20050084925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Method for producing cephalexin'
[patent_app_type] => utility
[patent_app_number] => 10/501140
[patent_app_country] => US
[patent_app_date] => 2003-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3636
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20050084925.pdf
[firstpage_image] =>[orig_patent_app_number] => 10501140
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/501140 | Method for producing cephalexin | Oct 15, 2003 | Issued |
Array
(
[id] => 7117410
[patent_doc_number] => 20050070711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-31
[patent_title] => 'Method for reducing residual alcohols in crystalline valacyclovir hydrochloride'
[patent_app_type] => utility
[patent_app_number] => 10/688538
[patent_app_country] => US
[patent_app_date] => 2003-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1730
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20050070711.pdf
[firstpage_image] =>[orig_patent_app_number] => 10688538
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/688538 | Method for reducing residual alcohols in crystalline valacyclovir hydrochloride | Oct 15, 2003 | Abandoned |
Array
(
[id] => 421933
[patent_doc_number] => 07273864
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-09-25
[patent_title] => 'Compositions and methods for inducing osteogenesis'
[patent_app_type] => utility
[patent_app_number] => 10/687220
[patent_app_country] => US
[patent_app_date] => 2003-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14845
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/273/07273864.pdf
[firstpage_image] =>[orig_patent_app_number] => 10687220
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/687220 | Compositions and methods for inducing osteogenesis | Oct 14, 2003 | Issued |
Array
(
[id] => 7338203
[patent_doc_number] => 20040132991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-08
[patent_title] => 'Novel taxanes and methods related to use and preparation thereof'
[patent_app_type] => new
[patent_app_number] => 10/683865
[patent_app_country] => US
[patent_app_date] => 2003-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14361
[patent_no_of_claims] => 126
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20040132991.pdf
[firstpage_image] =>[orig_patent_app_number] => 10683865
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/683865 | Novel taxanes and methods related to use and preparation thereof | Oct 8, 2003 | Abandoned |
Array
(
[id] => 5667826
[patent_doc_number] => 20060173176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'Process for the preparation of (z)-isomer enriched 7-amino-3-propen-1-yl-3-cephem-4-carboxylic acid'
[patent_app_type] => utility
[patent_app_number] => 10/530589
[patent_app_country] => US
[patent_app_date] => 2003-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4161
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20060173176.pdf
[firstpage_image] =>[orig_patent_app_number] => 10530589
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/530589 | Process for the preparation of (z)-isomer enriched 7-amino-3-propen-1-yl-3-cephem-4-carboxylic acid | Oct 7, 2003 | Abandoned |
Array
(
[id] => 7169564
[patent_doc_number] => 20040077666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => 'Nitrogen substituted biaryl purine derivatives as potent antiproliferative agents'
[patent_app_type] => new
[patent_app_number] => 10/680832
[patent_app_country] => US
[patent_app_date] => 2003-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58362
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20040077666.pdf
[firstpage_image] =>[orig_patent_app_number] => 10680832
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/680832 | Nitrogen substituted biaryl purine derivatives as potent antiproliferative agents | Oct 6, 2003 | Issued |
Array
(
[id] => 7226992
[patent_doc_number] => 20040073023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => '3-cephem derivative crystal'
[patent_app_type] => new
[patent_app_number] => 10/679451
[patent_app_country] => US
[patent_app_date] => 2003-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6623
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20040073023.pdf
[firstpage_image] =>[orig_patent_app_number] => 10679451
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/679451 | 3-cephem derivative crystal | Oct 6, 2003 | Issued |
Array
(
[id] => 5794272
[patent_doc_number] => 20060014953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes'
[patent_app_type] => utility
[patent_app_number] => 10/530215
[patent_app_country] => US
[patent_app_date] => 2003-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24113
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014953.pdf
[firstpage_image] =>[orig_patent_app_number] => 10530215
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/530215 | Beta-amino heterocyclic dipeptidyl peptidase inhibitors for diabetes | Oct 2, 2003 | Issued |
Array
(
[id] => 7238793
[patent_doc_number] => 20040157821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'Sulfate of cephem compound'
[patent_app_type] => new
[patent_app_number] => 10/473860
[patent_app_country] => US
[patent_app_date] => 2003-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6952
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20040157821.pdf
[firstpage_image] =>[orig_patent_app_number] => 10473860
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/473860 | Sulfate of cephem compound | Oct 2, 2003 | Abandoned |
Array
(
[id] => 7351941
[patent_doc_number] => 20040248908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents'
[patent_app_type] => new
[patent_app_number] => 10/677683
[patent_app_country] => US
[patent_app_date] => 2003-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44213
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248908.pdf
[firstpage_image] =>[orig_patent_app_number] => 10677683
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/677683 | Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents | Oct 1, 2003 | Issued |
Array
(
[id] => 658841
[patent_doc_number] => 07105659
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-12
[patent_title] => 'Process for preparing cefdinir'
[patent_app_type] => utility
[patent_app_number] => 10/676914
[patent_app_country] => US
[patent_app_date] => 2003-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1846
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/105/07105659.pdf
[firstpage_image] =>[orig_patent_app_number] => 10676914
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/676914 | Process for preparing cefdinir | Sep 30, 2003 | Issued |
Array
(
[id] => 21923
[patent_doc_number] => 07799524
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-21
[patent_title] => 'Substrates for O6-alkylguanina-DNA alkyltransferase'
[patent_app_type] => utility
[patent_app_number] => 10/529651
[patent_app_country] => US
[patent_app_date] => 2003-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18211
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/799/07799524.pdf
[firstpage_image] =>[orig_patent_app_number] => 10529651
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/529651 | Substrates for O6-alkylguanina-DNA alkyltransferase | Sep 30, 2003 | Issued |
Array
(
[id] => 5748634
[patent_doc_number] => 20060111566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Intermediate cefdinir salts'
[patent_app_type] => utility
[patent_app_number] => 10/529649
[patent_app_country] => US
[patent_app_date] => 2003-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2636
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20060111566.pdf
[firstpage_image] =>[orig_patent_app_number] => 10529649
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/529649 | Intermediate cefdinir salts | Sep 25, 2003 | Issued |
Array
(
[id] => 71897
[patent_doc_number] => 07754728
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-13
[patent_title] => 'Adenine compound and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/528343
[patent_app_country] => US
[patent_app_date] => 2003-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 42570
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/754/07754728.pdf
[firstpage_image] =>[orig_patent_app_number] => 10528343
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/528343 | Adenine compound and use thereof | Sep 25, 2003 | Issued |